Duquesne Family Office’s Teva Pharmaceuticals TEVA Stock Holding History

Duquesne Family Office’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$268M	Buy
2025 Q1	$229M	Buy
2024 Q4	$198M	Buy
2024 Q3	$25.7M	Buy
2015 Q2	–	Sell
2015 Q1	$49.2M	Buy
2014 Q3	–	Sell
2014 Q2	$65.1M	Hold
2014 Q1	$65.6M	Hold
2013 Q4	$49.7M	Buy